Brought to you by 
Crucell completes $119mm IPO
11 Jan 2001
Executive Summary
Dutch biotechnology company Crucell has completed an offering of 8mm newly issued ordinary shares priced at $14.80 apiece (Euro18) in an IPO on both the Amsterdam stock exchange (Euronext) and Nasdaq, raising $119mm.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Gene Therapy, Cell Therapy
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Crucell completes $119mm IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice